GENEVA, July 1 -- LEPU BIOPHARMA CO., LTD. filed a patent application (CN2025/140793) for “ANTI-CDH17 ANTIBODY-DRUG CONJUGATES AND USES THEREOF”. With publication no. WO/2026/124417, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....